植物化学物在肿瘤免疫治疗中的研究进展

doi:10.11904/j.issn.1002-3070.2025.05.010

Abstract

Abstract: In recent years,the incidence and mortality of malignant tumors have been increasing year by year,becoming a serious challenge to global public health.Unlike traditional treatment methods,tumor immunotherapy activates the body's own immune system to against tumors,and has significant advantage such as minimal side effects,long-lasting efficacy,and strong targeting.However,immunotherapy also has issues such as frequent adverse reactions and high treatment costs.In order to enhance the efficacy of immunotherapy,some phytochemicals are used in the field of immunotherapy as modulators.These phytochemicals not only increase the sensitivity of tumor cells to immune cells,but also reduce the expression of immune checkpoint proteins.Therefore,this article provides a review of phytochemicals that play an important role in tumor immunotherapy and their related mechanisms of action.

Key words: phytochemicals, tumor, immunotherapy

CLC Number:

ZHANG Xuan, LI Juan, FANG Chuanfeng, TIAN Hong, LIU Jiaren. Research progress of phytochemicals in tumor immunotherapy[J]. Journal of Practical Oncology, 2025, 39(5): 428-432.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2025.05.010

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2025/V39/I5/428

References

1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
2 Deng LJ,Wang LH,Peng CK,et al.Fibroblast activation protein α activated tripeptide bufadienolide antitumor prodrug with reduced cardiotoxicity[J].J Med Chem,2017,60(13):5320-5333.
3 Agarwal G,Carcache PJB,Addo EM,et al.Current status and contemporary approaches to the discovery of antitumor agents from higher plants[J].Biotechnol Adv,2020,38(1):107337.
4 Yang Y,Liu Q,Shi X,et al.Advances in plant-derived natural products for antitumor immunotherapy[J].Arch Pharm Res,2021,44(11):987-1011.
5 Weng W,Goel A.Curcumin and colorectal cancer:an update and current perspective on this natural medicine[J].Semin Cancer Biol,2022,80(3):73-86.
6 Liao F,Liu L,Luo E,et al.Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma[J].Arch Oral Biol,2018,92(8):32-37.
7 Maruyama T,Miyazaki H,Lim YJ,et al.Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucose[J].Front Immunol,2023,14(1):1049713.
8 Shao Y,Zhu W,Da J,et al.Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer[J].Onco Targets Ther,2017,10(5):2675-2683.
9 Galiniak S,Aebisher D,Bartusik-Aebisher D.Health benefits of resveratrol administration[J].Acta Biochim Pol,2019,66(1):13-21.
10 Verdura S,Cuyàs E,Cortada E,et al.Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity[J].Aging(Albany NY),2020,12(1):8-34.
11 Lin CC,Chin YT,Shih YJ,et al.Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells[J].J Dent Sci,2019,14(3):255-262.
12 Zhang Y,Yang S,Yang Y,et al.Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells[J].Infect Agent Cancer,2019,14(10):27.
13 Wang YC,Huang KM.In vitro anti-inflammatory effect of apigenin in the helicobacter pylori-infected gastric adenocarcinoma cells[J].Food Chem Toxicol,2013,53(4):376-383.
14 Coombs MRP,Harrison ME,Hoskin DW.Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells[J].Cancer Lett,2016,380(2):424-433.
15 Xu L,Zhang Y,Tian K,et al.Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects[J].J Exp Clin Cancer Res,2018,37(1):1-15.
16 Ren M,Zhao Y,He Z,et al.Baicalein inhibits inflammatory response and promotes osteogenic activity in periodontal ligament cells challenged with lipopolysaccharides[J].BMC Complement Med Ther,2021,21(1):1-11.
17 Ke M,Zhang Z,Xu B,et al.Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells[J].Int Immunopharmacol,2019,75(11):105824.
18 Song L,Zhu S,Liu C,et al.Baicalin triggers apoptosis,inhibits migration,and enhances anti-tumor immunity in colorectal cancer via TLR4/NF-κB signaling pathway[J].J Food Biochem,2022,46(3):e13703.
19 Zhu L,Chen L.Progress in research on paclitaxel and tumor immunotherapy[J].Cell Mol Biol Lett,2019,24(6):1-11.
20 Matsuhashi T,Shimizu M,Negishi Y,et al.A low,non-toxic dose of paclitaxel can prevent dendritic cell-precursors from becoming tolerogenic dendritic cells with impaired functions[J].Biomed Res,2014,35(6):369-380.
21 Byun JW,Lee HS,Song SU,et al.Combined treatment of murine fibrosarcoma with chemotherapy(Paclitaxel),radiotherapy,and intratumoral injection of dendritic cells[J].Ann Dermatol,2014,26(1):53-60.
22 Konstat-Korzenny E,Ascencio-Aragón JA,Niezen-Lugo S,et al.Artemisinin and its synthetic derivatives as a possible therapy for cancer[J].Med Sci(Basel),2018,6(1):1-10.
23 Houh YK,Kim KE,Park S,et al.The effects of artemisinin on the cytolytic activity of natural killer(NK)cells[J].Int J Mol Sci,2017,18(7):1-11.
24 Cui C,Feng H,Shi X,et al.Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10[J].Int Immunopharmacol,2015,27(1):110-121.
25 Cao Y,Feng YH,Gao LW,et al.Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo[J].Int Immunopharmacol,2019,70(5):110-116.
26 Güçlü-Ustündağ O,Mazza G.Saponins:properties,applications and processing[J].Crit Rev Food Sci Nutr,2007,47(3):231-258.
27 Ye Z,Ding J,Huang J,et al.Ginsenoside rg3 activates the immune function of CD8⁺T cells via circFOXP1-miR-4477a-PD-L1 axis to induce ferroptosis in gallbladder cancer[J].Arch Pharm Res,2024,47(10-11):793-811.
28 Chen Y,Zhang Y,Song W,et al.Ginsenoside rh2 improves the cisplatin anti-tumor effect in lung adenocarcinoma A549 cells via superoxide and PD-L1[J].Anticancer Agents Med Chem,2020,20(4):495-503.
29 Hu M,Yang J,Qu L,et al.Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma[J].Food Funct,2020,11(1):456-471.
30 Bailly C,Thuru X,Quesnel B.Combined cytotoxic chemotherapy and immunotherapy of cancer:modern times[J].NAR Cancer,2020,2(1):zcaa002.
31 Bedi D,Henderson HJ,Manne U,et al.Camptothecin induces PD-L1 and immunomodulatory cytokines in colon cancer cells[J].Medicines(Basel),2019,6(2):1-12.
32 Sato H,Niimi A,Yasuhara T,et al.DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells[J].Nat Commun,2017,8(1):17-51.
33 Surh YJ,Lee SS.Capsaicin,a double-edged sword:toxicity,metabolism,and chemopreventive potential[J].Life Sci,1995,56(22):1845-1855.
34 Beltran J,Ghosh AK,Basu S.Immunotherapy of tumors with neuroimmune ligand capsaicin[J].J Immunol,2007,178(5):3260-3264.
35 Jin T,Wu H,Wang Y,et al.Capsaicin induces immunogenic cell death in human osteosarcoma cells[J].Exp Ther Med,2016,12(2):765-770.

[1]	ZHOU Suxia, XU Zhihua, GUO Shuling, FAN Ning, XU Lili. Analysis for the prevalence trend of malignant tumor incidence and mortality in cancer registration areas in Qinghai Province from 2014 to 2021 [J]. Journal of Practical Oncology, 2025, 39(5): 381-387.
[2]	LIU Yang, WANG Ying, MA Xiang, SONG JiaBao, LIU DaMin, CHEN Lili. Analysis of incidence and mortality of malignant tumors among urban residents in Yingkou City,Liaoning Province in 2021 [J]. Journal of Practical Oncology, 2025, 39(5): 400-404.
[3]	XIN Xin, XIONG Wenjing, ZHANG Chunnuan, LI Xiaojing, GAO Xue, ZHANG Yue. Lactylation modification:an emerging target in cancer therapy [J]. Journal of Practical Oncology, 2025, 39(5): 433-436.
[4]	DAI Xiaoze, MA Yuxia, LI Yuting, QI Xiaoqing, ZHU Tiancen, MU Huijuan, LIU Hui. Analysis of the incidence and mortality trends of malignant tumors among urban residents in Fuxin City,Liaoning Province from 2014 to 2020 [J]. Journal of Practical Oncology, 2025, 39(4): 278-283.
[5]	ZHU Tiancen, LI Yanxia, REN Fanghan, DAI Xiaoze, LIU Yang, MU Huijuan. Analyses for the epidemic situation of malignant tumors in cancer registration areas of Liaoning Province in 2021 [J]. Journal of Practical Oncology, 2025, 39(4): 294-300.
[6]	LI Xiaotong, MIAO Miao, HOU Kaijiong, CHEN Hong. Research progress in the impact of GATA4 on tumors [J]. Journal of Practical Oncology, 2025, 39(4): 338-342.
[7]	CAO Jingjing, ZHANG Gong. Progress in the application of electric field therapy for tumor in the treatment of glioblastoma [J]. Journal of Practical Oncology, 2025, 39(4): 353-357.
[8]	LIANG Xiaodan, GUO Haonan. Research advances on the CDC5L gene in malignant tumors [J]. Journal of Practical Oncology, 2025, 39(4): 358-362.
[9]	LI Ji, ZHANG Maorong, YANG Zhao, WEN Hongmei, WU Fuxian, LI Yuntao. Analyses for the incidence and mortality characteristics of malignant tumors in the cancer registration areas of Kunming City,Yunnan Province in 2020 and their trend from 2016 to 2020 [J]. Journal of Practical Oncology, 2025, 39(3): 169-176.
[10]	LI Dongsheng, LI Zehao, CHEN Yonggang. Application of DNA methylation risk scoring model for ferroptosis related genes in the prognosis and immune feature assessment of colon cancer [J]. Journal of Practical Oncology, 2025, 39(3): 224-234.
[11]	YE Qianni, LI Juan, WANG Falin, LIU Jiaren. Research progress on the role of phytochemicals in tumor microenvironment [J]. Journal of Practical Oncology, 2025, 39(3): 245-250.
[12]	WU Xu, DE Leheibateer, DA Lintai, SU Nite, LIU Jun. Research progress of long non-coding RNA in oral squamous cell carcinoma [J]. Journal of Practical Oncology, 2025, 39(3): 251-255.
[13]	WEN Xiaoyan, CHEN Li. Comparative analysis of the burden of malignant tumors among the people aged 30 and above in Sichuan province in 2010 and 2020 [J]. Journal of Practical Oncology, 2025, 39(1): 1-6.
[14]	MA Ming, WANG Wanying, RUAN Yuli, LIU Chao, ZHANG Yanqiao, MA Zhigang. The values of systemic inflammatory immune nutritional score in predicting the prognosis of immunotherapy for advanced gastric cancer [J]. Journal of Practical Oncology, 2025, 39(1): 39-48.
[15]	LI Caizheng, ZHENG Jing, SU Qiaoli. Advance progress in immunotherapy for unresectable locally advanced non-small cell lung cancer [J]. Journal of Practical Oncology, 2025, 39(1): 67-72.

Research progress of phytochemicals in tumor immunotherapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments